FibroBiologics, Inc.
FBLG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001958777
No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $269.6K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in FibroBiologics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +17 vs. Q4 2023
- Shares held
- 480.4K
- +480.4K vs. Q4 2023
- Total value
- $5.18M
- +$5.18M vs. Q4 2023
- New holders
- 17
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBLG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $269.6K |
| Q1 2026 | 17 | $291.1K |
| Q4 2025 | 46 | $993.8K |
| Q3 2025 | 55 | $2.93M |
| Q2 2025 | 59 | $3.75M |
| Q1 2025 | 65 | $5.81M |
| Q4 2024 | 64 | $11.9M |
| Q3 2024 | 61 | $16.8M |
| Q2 2024 | 50 | $17.2M |
| Q1 2024 | 17 | $5.18M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding FibroBiologics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 209,231 | $2.26M | 0.00% | +209,231 | New |
| HRT Financial LP | 57,344 | $619.0K | 0.00% | +57,344 | New |
| Marshall Wace, LLP | 52,025 | $562.4K | 0.00% | +52,025 | New |
| Citigroup Inc | 30,419 | $328.8K | 0.00% | +30,419 | New |
| ExodusPoint Capital Management, LP | 25,591 | $277.0K | 0.00% | +25,591 | New |
| JPMorgan Chase & Co | 22,634 | $244.7K | 0.00% | +22,634 | New |
| GWM Advisors LLC | 17,906 | $193.6K | 0.00% | +17,906 | New |
| Point72 (DIFC) Ltd | 15,915 | $172.0K | 0.01% | +15,915 | New |
| Balyasny Asset Management LLC | 14,246 | $154.0K | 0.00% | +14,246 | New |
| BlackRock Inc. | 13,190 | $142.6K | 0.00% | +13,190 | New |
| Geode Capital Management, LLC | 10,989 | $118.8K | 0.00% | +10,989 | New |
| Cubist Systematic Strategies, LLC | 8,978 | $97.1K | 0.00% | +8,978 | New |
| Royal Bank of Canada | 400 | $4.00K | 0.00% | +400 | New |
| Allworth Financial LP | 261 | $2.82K | 0.00% | +261 | New |
| Wells Fargo & Company | 200 | $2.16K | 0.00% | +200 | New |
| UBS Group AG | 28 | $303 | 0.00% | +28 | New |
| Macquarie Group Ltd | 1,073 | $12 | 0.00% | +1,073 | New |